Reuters logo
BRIEF-Theraclion announces progress towards market access for Echopulse in the U.S.
October 26, 2017 / 6:19 AM / a month ago

BRIEF-Theraclion announces progress towards market access for Echopulse in the U.S.

Oct 26 (Reuters) - THERACLION SA

* THERACLION MAKES SUBSTANTIAL PROGRESS TOWARDS MARKET ACCESS FOR ECHOPULSE® IN THE US

* ‍PIVOTAL TRIAL FOR BREAST FIBROADENOMA AT OVER 25% TREATMENT COMPLETION:​ Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below